Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 26 Jul 23 EFFECT Notice of effectiveness
- 24 Jul 23 POS AM Prospectus update (post-effective amendment)
- 31 Mar 23 EFFECT Notice of effectiveness
- 28 Mar 23 POS AM Prospectus update (post-effective amendment)
- 9 Mar 23 424B3 Prospectus supplement
- 7 Mar 23 424B3 Prospectus supplement
- 1 Feb 23 424B3 Prospectus supplement
- 9 Jan 23 424B3 Prospectus supplement
- 9 Nov 22 424B3 Prospectus supplement
- 12 Oct 22 424B3 Prospectus supplement
- 6 Oct 22 424B3 Prospectus supplement
- 6 Oct 22 EFFECT Notice of effectiveness
-
26 Sep 22 S-1 IPO registration
GRNA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated March 31, 2022, (September 26, 2022, as to the effects of the reverse recapitalization described in Note 1), relating to the financial statements of GreenLight Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
September 26, 2022